Literature DB >> 2845743

Histamine H1-receptors mediate phosphoinositide and calcium response in cultured smooth muscle cells--interaction with cicletanine (CIC).

M O Lonchampt1, P Marche, C Demerle, A Girard, M Cabanie, A Esanu, P E Chabrier, P Braquet.   

Abstract

Smooth muscle cells were cultured from guinea-pig aorta and labelled with 45Ca++ and 32Pi to investigate the possible effect of cicletanine, a new antihypertensive drug, on the release of intracellular Ca++ and the metabolism of phosphoinositide induced by histamine. In 45Ca++ labelled cells, histamine increased in a dose-dependent manner the 45Ca++ efflux in the first two minutes. Stimulation of 45Ca++ release was observed with H1-agonist [2-pyridylethylamine dihydrochloride (2-PEA)] but not with H2-agonist (dimaprit). In addition, histamine- or 2-PEA- induced 45Ca++ efflux was inhibited by the H1-antagonists (mepyramine and terfenadine) whereas the H2-antagonist (cimetidine) was without effect. Similar results were obtained in 32Pi labelled cells; both H1-agonists (histamine and 2-PEA) increased the labelling of phosphoinositides. This effect was completely blocked by mepyramine. These results demonstrate that the histamine-induced stimulation of 45Ca++ efflux and phosphoinositide metabolism are mediated through H1-receptors. In the above systems, cicletanine was as effective as the H1-antagonist (mepyramine) with an IC50 of 10(-6) M for both 45Ca++ efflux and phosphoinositide metabolism. Blockade of these systems by cicletanine may be part of the mechanism by which this drug produces relaxation of blood vessels and may account for its in vivo antihypertensive action.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845743     DOI: 10.1007/bf02028280

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  The relationship between calcium ion gates and the stimulation of phosphatidylinositol turnover.

Authors:  S S Jafferji; R H Michell
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

2.  Competitive and stereoselective histamine H1 antagonistic effect of cicletanide in guinea-pig isolated ileum.

Authors:  P Schoeffter; J Ghysel-Burton; M Cabanie; T Godfraind
Journal:  Eur J Pharmacol       Date:  1987-04-14       Impact factor: 4.432

3.  Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.

Authors:  R D Brown; P Prendiville; C Cain
Journal:  Mol Pharmacol       Date:  1986-06       Impact factor: 4.436

4.  Increase in histamine concentrations in discrete hypothalamic nuclei of spontaneously hypertensive rats.

Authors:  F M Correa; J M Saavedra
Journal:  Brain Res       Date:  1981-02-02       Impact factor: 3.252

5.  Calcium-dependent turnover of brain polyphosphoinositides in vitro after prelabelling in vivo.

Authors:  J Jolles; L H Schrama; W H Gispen
Journal:  Biochim Biophys Acta       Date:  1981-10-23

6.  Detection of histamine receptors at cellular level.

Authors:  C Heltianu; M Simionescu; N Simionescu
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

7.  Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle.

Authors:  R W Alexander; T A Brock; M A Gimbrone; S E Rittenhouse
Journal:  Hypertension       Date:  1985 May-Jun       Impact factor: 10.190

8.  Phorbol ester effects on alpha 1-adrenoceptor binding and phosphatidylinositol metabolism in cultured vascular smooth muscle cells.

Authors:  S Cotecchia; L M Leeb-Lundberg; P O Hagen; R J Lefkowitz; M G Caron
Journal:  Life Sci       Date:  1985-12-23       Impact factor: 5.037

9.  Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris.

Authors:  R Ginsburg; M R Bristow; N Kantrowitz; D S Baim; D C Harrison
Journal:  Am Heart J       Date:  1981-11       Impact factor: 4.749

10.  Chronotropic and dromotropic effects of histamine on the canine heart.

Authors:  G R Hageman; F Urthaler; J H Isobe; T N James
Journal:  Chest       Date:  1979-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.